Search research articles
Contact Us
Filters
Showing results (251-260 of 257) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 257 results.
Diabetes, Obesity & Metabolism
|
October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
L L Ilag, M A Deeg, T Costigan, et al.
Nature Communications
|
June 18, 2015
Artificial membrane-binding proteins stimulate oxygenation of stem cells during engineering of large cartilage tissue
James P K Armstrong, Rameen Shakur, Joseph P Horne, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2010
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
M S Kipnes, P Hollander, K Fujioka, et al.
Biomaterials
|
August 4, 2009
A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial
M Adelaide Asnaghi, Philipp Jungebluth, Manuela T Raimondi, et al.
Science (New York, N.Y.)
|
April 14, 1978
The LDH virus: an interfering biological contaminant
V Riley, D H Spackman, G A Santisteban, et al.
Lancet (London, England)
|
November 22, 2008
Clinical transplantation of a tissue-engineered airway
Paolo Macchiarini, Philipp Jungebluth, Tetsuhiko Go, et al.
Stem Cells (Dayton, Ohio)
|
August 24, 2017
The Wnt5a Receptor, Receptor Tyrosine Kinase-Like Orphan Receptor 2, Is a Predictive Cell Surface Marker of Human Mesenchymal Stem Cells with an Enhanced Capacity for Chondrogenic Differentiation
Sally C Dickinson, Catherine A Sutton, Kyla Brady, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 257) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 257 results.
Diabetes, Obesity & Metabolism
|
October 6, 2015
Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
L L Ilag, M A Deeg, T Costigan, et al.
Nature Communications
|
June 18, 2015
Artificial membrane-binding proteins stimulate oxygenation of stem cells during engineering of large cartilage tissue
James P K Armstrong, Rameen Shakur, Joseph P Horne, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2010
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
M S Kipnes, P Hollander, K Fujioka, et al.
Biomaterials
|
August 4, 2009
A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial
M Adelaide Asnaghi, Philipp Jungebluth, Manuela T Raimondi, et al.
Science (New York, N.Y.)
|
April 14, 1978
The LDH virus: an interfering biological contaminant
V Riley, D H Spackman, G A Santisteban, et al.
Lancet (London, England)
|
November 22, 2008
Clinical transplantation of a tissue-engineered airway
Paolo Macchiarini, Philipp Jungebluth, Tetsuhiko Go, et al.
Stem Cells (Dayton, Ohio)
|
August 24, 2017
The Wnt5a Receptor, Receptor Tyrosine Kinase-Like Orphan Receptor 2, Is a Predictive Cell Surface Marker of Human Mesenchymal Stem Cells with an Enhanced Capacity for Chondrogenic Differentiation
Sally C Dickinson, Catherine A Sutton, Kyla Brady, et al.
Page
of 26